Showing 641 - 660 results of 224,747 for search '(( 50 ((we decrease) OR (teer decrease)) ) OR ( 10 ((a decrease) OR (nn decrease)) ))', query time: 1.29s Refine Results
  1. 641
  2. 642
  3. 643
  4. 644

    The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin... by Chanel Avenant (409756)

    Published 2025
    “…Both contraceptives substantially decreased, from D0 to 25W, the total testosterone [DMPA-IM D0 0.560, 25W 0.423 nmol/L, -24.3% (p < 0.0001); NET-EN D0 0.551, 25W 0.253 nmol/L, -54.1%, (p < 0.0001)], SHBG [DMPA-IM D0 45.0, 25W 32.7 nmol/L, -29.8% (p < 0.0001); NET-EN D0 50.2, 25W 17.6 nmol/L, -65.1% (p < 0.0001)], and calculated free testosterone levels [DMPA-IM D0 6.87, 25W 5.38 pmol/L, -17.2% (p = 0.0371); NET-EN D0 6.00, 25W 3.70, -40.0% (p < 0.0001)]. …”
  5. 645
  6. 646
  7. 647

    Forced WNT10A expression and WNT10A siRNA knockdown in kidney cell lines. by Ren-Jun Hsu (127121)

    Published 2012
    “…Conversely, RCC-1 and Caki-1 transfected with WNT10A siRNA showed significant decrease in cell proliferation as compared to cells transfected with reagent and scrambled siRNA controls. …”
  8. 648

    Compound CID 9998128 Is a Potential Multitarget Drug for Alzheimer’s Disease by Nguyen Quoc Thai (5348798)

    Published 2018
    “…Moreover, the compound dose-dependently decreases β-site amyloid precursor protein cleaving enzyme (BACE-1) activity with EC<sub>50</sub> value in micromolar range. …”
  9. 649

    Compound CID 9998128 Is a Potential Multitarget Drug for Alzheimer’s Disease by Nguyen Quoc Thai (5348798)

    Published 2018
    “…Moreover, the compound dose-dependently decreases β-site amyloid precursor protein cleaving enzyme (BACE-1) activity with EC<sub>50</sub> value in micromolar range. …”
  10. 650
  11. 651
  12. 652

    Resveratrol decreases proliferation of Cisplatin-sensitive A2780 cells but not Cisplatin-resistant A2780CP cells. by Sébastien Baribeau (512869)

    Published 2014
    “…<p>MTT assay was performed to evaluate A2780 and A2780 cell lines proliferation in response to 10 µM Cisplatin and increasing doses up to 60 µM of Resveratrol. …”
  13. 653

    Loss of <i>flp-1</i> decreases the nose touch response. by Ingrid Buntschuh (4729536)

    Published 2018
    “…<p>All <i>flp-1</i> and <i>daf-10</i> mutant alleles showed a decreased nose touch response. …”
  14. 654
  15. 655
  16. 656
  17. 657
  18. 658
  19. 659
  20. 660